Pulmocide Announces Nature Research Publication Showing PC945 in Combination with Standard Antifungal Treatment Causes a Synergistic Effect Against Aspergillus Fumigatus July 8, 2019
Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with Pfizer’s CDK4/6 Inhibitor Palbociclib July 2, 2019
PTC Therapeutics Announces Strategic Gene Therapy Licensing Agreement with Odylia Therapeutics July 2, 2019
Bicycle Therapeutics Announces Positive Topline Results from Oxurion’s Phase I Trial Using a Novel Bicycle-based Plasma Kallikrein Inhibitor for the Treatment of Diabetic Macular Edema July 1, 2019
Axial Therapeutics Announces $10M Investment from Taiho Ventures to Access Axial’s Expertise in the Gut-Brain Axis June 24, 2019
Calithera Achieves Positive Topline Results in Randomized Phase 2 Study in Renal Cell Carcinoma June 18, 2019
